Kamali F, Fry J R, Bell G D
J Pharm Pharmacol. 1987 Feb;39(2):150-2. doi: 10.1111/j.2042-7158.1987.tb06967.x.
Plasma and saliva paracetamol levels were measured by HPLC in ten healthy volunteers who took a therapeutic dose after an overnight fast. Salivary levels of the drug were consistently and significantly higher than those in plasma for the first 50 min after oral ingestion, but saliva and plasma levels correlated closely during the elimination phase. There was a highly significant correlation between the AUC 0-alpha calculated from saliva and plasma paracetamol concentration-time curves. The elevated saliva/plasma ratio for the first 50 min was not due to loss of paracetamol from plasma during sample preparation, binding to plasma protein or adsorption to the buccal mucosa. Administration of probenecid in an attempt to block possible active secretion of paracetamol into saliva did not significantly alter the saliva/plasma concentration ratio for the first 50 min, but did significantly reduce this ratio in the time period 125-360 min. The experimental data conformed to a recently proposed model in which elevated saliva/plasma ratios during the early stages following oral ingestion were related to ongoing absorption into the arterial system.
采用高效液相色谱法(HPLC)测定了10名健康志愿者在禁食过夜后服用治疗剂量对乙酰氨基酚后的血浆和唾液中对乙酰氨基酚水平。口服摄入后最初50分钟内,唾液中药物水平始终显著高于血浆中的水平,但在消除阶段,唾液和血浆水平密切相关。从唾液和血浆对乙酰氨基酚浓度 - 时间曲线计算出的AUC0-α之间存在高度显著的相关性。最初50分钟唾液/血浆比值升高并非由于样品制备过程中血浆中对乙酰氨基酚的损失、与血浆蛋白结合或吸附到颊粘膜。试图通过给予丙磺舒来阻断对乙酰氨基酚可能的主动分泌进入唾液,在最初50分钟内并未显著改变唾液/血浆浓度比值,但在125 - 360分钟时间段内确实显著降低了该比值。实验数据符合最近提出的一个模型,即在口服摄入后的早期阶段,唾液/血浆比值升高与持续吸收进入动脉系统有关。